Deficiency of the mitochondrial transporter of aspartate/glutamate aralar/AGC1 causes hypomyelination and neuronal defects unrelated to myelin deficits in mouse brain

Journal of Neuroscience Research

Volumn 89, Issue 12, 2011, Pages 2008-2017

  Ramos, Milagros ^a,b   Pardo, Beatriz ^a   Llorente Folch, Irene ^a   Saheki, Takeyori ^c   del Arco, Araceli ^a,d   Satrústegui, Jorgina ^a  

^a CSIC   (Spain)

^b UNIVERSIDAD POLITÉCNICA DE MADRID   (Spain)

^c TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^d UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

Aralar AGC1; Aspartate glutamate mitochondrial carrier; Glutamine; Myelination; N acetyl aspartate; Neurofilaments; Oligodendrocyte; OmniBank

Indexed keywords

ARALAR; ASPARTIC ACID; CARRIER PROTEIN; GLUTAMIC ACID; MYELIN; N ACETYLASPARTIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; GRAY MATTER; LIPOGENESIS; MALE; MOUSE; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PURKINJE CELL; PYRAMIDAL NERVE CELL; WHITE MATTER;

ANIMALS; BRAIN; CELLS, CULTURED; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYELIN SHEATH; OLIGODENDROGLIA; SYNAPTIC TRANSMISSION;

EID: 80053641826     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22639     Document Type: Article

References (46)

1. Ariyannur PS, Moffett JR, Manickam P, Pattabiraman N, Arun P, Nitta A, Nabeshima T, Madhavarao CN, Namboodiri AMA. 2010a. Methamphetamine-induced neuronal protein NAT8L is the NAA biosynthetic enzyme: Implications for specialized acetyl coenzyme A metabolism in the CNS. Brain Res 1335: 1-13.
2. Ariyannur PS, Moffett JR, Madhavarao CN, Arun Pishnu N, Jacobowitz DM, Hallows WC, Denu JM, Namboodiri AMA. 2010b. Nuclear-cytoplasmic localization of acetyl coenzyme a synthetase-1 in the rat brain. J Comp Neurol 518: 2952-2977.
3. Bjartmar C, Battistuta J, Terada N, Dupree E, Trapp BD. 2002. N-acetylaspartate is an axon-specific marker of mature white matter in vivo: a biochemical and immunochemical study on the rat optic nerve. Ann Neurol 51: 51-58.
4. 13C MRS at 1.5 T. J Magn Reson 136: 219-225.
5. Bosio A, Binczek E, Stoffel W. 1996. Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis. Proc Natl Acad Sci U S A 93: 13280-13285.
6. Butt AM, Ibrahim M, Berry M. 1997. The relationship between developing oligodendrocyte units and maturing axons during myelinogenesis in the anterior medullary velum of neonatal rats. J Neurocytol 26: 327-338.
7. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, Xing Y, Lubischer JL, Krieg PA, Krupenko SA, Thompson WJ, Barres BA. 2008. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci 28: 264-278.
8. Chakraborty G, Mekala P, Yahya D, Wu G, Ledeen RW. 2001. Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. J Neurochem 78: 736-745.
9. Coetzee T, Fujita N, Dupree J, Shi R, Blight A, Suzuki K, Suzuki K, Popko B. 1996. Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability. Cell 86: 209-219.
10. Coetzee T, Dupree JL, Popko B. 1998. Demyelination and altered expression of myelin-associated glycoprotein isoforma in the central nervous system of galactolipid-deficient mice. J Neurosci Res 54: 613-622.
11. Contreras L, Urbieta A, Kobayashi K, Saheki T, Satrústegui J. 2010. Low levels of citrin (SLC25A13) expression in adult mouse brain restricted to neuronal clusters. J Neurosci Res 88: 1009-1016.
12. Dawson MRL, Levine JM, Reynolds R. 2000. NG2-expressing cells in the central nervous system: are they oligodendroglial progenitors? J Neurosci Res 61: 471-479.
13. Dugas JC, Tai YC, Speed TP, Ngai J, Barres BA. 2006. Functional genomic analysis of oligodendrocyte differentiation. J Neurosci 26: 10967-10983.
14. Dyer CA, Kendler A, Jean-Guillaume D, Awatramani R, Lee A, Mason LM, Kamholz J. 2000. GFAP-positive and myelin marker-positive glia in normal and pathologic environments. J Neurosci Res 60: 412-426.
15. +-dependent high-affinity dicarboxylate transporter NaDC3 and its relevance to the expression of the transporter in the brain. J Pharmacol Exp Ther 295: 392-403.
16. Jalil MA, Begum L, Contreras L, Pardo B, Iijima M, Li MX, Ramos M, Marmol P, Horiuchi M, Shimotsu K, Nakagawa S, Okubo A, Sameshima M, Isashiki Y, Del Arco A, Kobayashi K, Satrústegui J, Saheki T. 2005. Reduced N-acetylaspartate levels in mice lacking aralar, a brain- and muscle-type mitochondrial aspartate-glutamate carrier. J Biol Chem 280: 31333-31339.
17. Kitada K, Akimitsu T, Shigematsu Y, Kondo A, Maihara T, Yokoi N, Kuramoto T, Sasa M, Serikawa T. 2000. Accumulation of N-acetyl-L-aspartate in the brain of the tremor rat, a mutant exhibiting absence-like seizure and spongiform degeneration in the central nervous system. J Neurochem 74: 2512-2519.
18. Kolodziejczyk K, Hamilton NB, Wade A, Karadottir R, Attwell D. 2009. The effect of N-acetyl-aspartyl-glutamate and N-acetyl-aspartate on white matter oligodendrocytes. Brain 132: 1496-1508.
19. Kumar S, Biancotti JC, Matalon R, de Vellis J. 2009. Lack of aspartoacylase activity disrupts survival and differentiation of neural progenitors and oligodendrocytes in a mouse model of Canavan disease. J Neurosci Res 87: 3415-3427.
20. LaNoue KF, Tischler ME. 1974. Electrogenic characteristics of the mitochondrial glutamate-aspartate antiporter. J Biol Chem 249: 7522-7528.
21. Liebner S, Corada M, Bangsow T, Babbage J, Taddei A, Czupalla CJ, Reis M, Felici A, Wolburg H, Fruttiger M, Taketo MM, von Melchner H, Plate KH, Gerhardt H, Dejana E. 2008. Wnt/beta-catenin signaling controls development of the blood-brain barrier. J Cell Biol 183: 409-417.
22. Madhavarao CN, Arun P, Moffett JR, Szucs S, Surendran S, Matalon R, Garbern J, Hristova D, Johnson A, Jiang W, Namboodiri MA. 2005. Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease. Proc Natl Acad Sci U S A 102: 5221-5226.
23. Marcus J, Dupree JL, Popko B. 2000. Effects of galactolipid elimination on oligodendrocyte development and myelination. Glia 30: 319-328.
24. Marcus J, Popko B. 2002. Galactolipids are molecular determinants of myelin development and axo-glial organization. Biochim Biophys Acta 1573: 406-413.
25. Matalon R, Rady PL, Platt KA, Skinner HB, Quast MJ, Campbell GA, Matalon K, Ceci JD, Tyring SK, Nehls M, Surendran S, Wei J, Ezell EL, Szucs S. 2000. Knock-out mouse for Canavan disease: a model for gene transfer to the central nervous system. J Genet Med 2: 165-175.
26. Mattan NS, Ghiani CA, Lloyd M, Matalon R, Bok D, Casaccia P, de Vellis J. 2010. Aspartoacylase deficiency affects early postnatal development of oligodendrocytes and myelination. Neurobiol Dis 40: 432-443.
27. McCarthy KD, De Vellis J. 1980. Preparation of separate astroglial and oligodendroglial cell cultures fron rat cerebral tissue. J Cell Biol 85: 890-902.
28. Mehta V, Namboodiri MA. 1995. N-acetylaspartate as an acetyl source in the nervous system. Brain Res Mol Brain Res 31: 151-157.
29. Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AM. 2007. N-acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 81: 89-131.
30. Molinari F, Raas-Rothschild A, Rio M, Fiermonte G, Encha-Razavi F, Palmieri L, Palmieri F, Ben-Neriah Z, Kadhom N, Vekemans M, Attie-Bitach T, Munnich A, Rustin P, Colleaux L. 2005. Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy. Am J Hum Genet 76: 334-339.
31. Molinari F, Kaminska A, Fiermonte G, Boddaert N, Raas-Rothschild A, Plouin P, Palmieri L, Brunelle F, Palmieri F, Dulac O, Munnich A, Colleaux L. 2009. Mutations in the mitochondrial glutamate carrier SLC25A22 in neonatal epileptic encephalopathy with suppression bursts. Clin Genet 76: 188-194.
32. Nave K-A. 2010. Myelination and the trophic support of long axons. Nat Rev Neurosci 11: 275-283.
33. Niwa M, Nitta A, Mizoguchi H, Ito Y, Noda Y, Nagai T, Nabeshima T. 2007. A novel molecule "shati" is involved in methamphetamine-induced hyperlocomotion, sensitization, and conditioned place preference. J Neurosci 27: 7604-7615.
34. Occhipinti R, Somersalo E, Calvetti D. 2010. Energetics of inhibition: insights with a computational model of the human GABAergic neuron-astrocyte cellular complex. J Cerebr Blood Flow Metab 30: 1834-1846.
35. Pardo B, Rodrigues TB, Contreras L, Garzón M, Llorente-Folch I, Kobayashi K, Saheki T, Cerdan S, Satrústegui J. 2011. Brain glutamine synthesis requires neuronal-born aspartate as amino donor for glial glutamate formation. J Cereb Blood Flow Metab 31: 90-101.
36. Sakurai T, Ramoz N, Barreto M, Gazdoiu M, Takahashi N, Gertner M, Dorr N, Gama Sosa MA, De Gasperi R, Perez G, Schmeidler J, Mitropoulou V, Le HC, Lupu M, Hof PR, Elder GA, Buxbaum JD. 2010. Slc25a12 disruption alters myelination and neurofilaments: a model for a hypomyelination syndrome and childhood neurodevelopmental disorders. Biol Psychiatry 67: 887-894.
37. 2+ signaling in neuronal mitochondria. J Neurosci Res 85: 3359-3366.
38. Satrústegui J, Pardo B, del Arco A. 2007b. Mitochondrial transporters as novel targets for intracellular calcium signaling. Physiol Rev 87: 29-67.
39. Sherman DL, Brophy PJ. 2005. Mechanisms of axon ensheathment and myelin growth. Nat Rev Neurosci 6: 683-690.
40. Sommer I, Schachner M. 1981. Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: An immunocytological study in the central nervous system. Dev Biol 83: 311-327.
41. Traka MWollmann RL, Cerda SR, Dugas J, Barres BA, Popko B. 2008. Mur7 is a nonsense mutation in the aspartoacylae gene that cuases spongy degeneration of the CNS. J Neurosci 28: 11537-11549.
42. Urenjak J, Williams SR, Gadian DG, Noble M. 1993. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13: 981-989.
43. Wiame E, Tyteca D, Pierrot N, Collard F, Amyere M, Noel G, Desmedt J, Nassogne MC, Vikkula M, Octave JN, Vincent MF, Courtoy PJ, Boltshauser E, van Schaftingen E. 2010. Molecular identification of aspartate N-acetyltransferase and its mutation in hypoacetylaspartia. Biochem J 425: 127-136.
44. Wibom R, Lasorsa FM, Töhönen V, Barbaro M, Sterky FH, Kucinski T, Naess K, Jonsson M, Pierri CL, Palmieri F, Wedell A. 2009. AGC1 deficiency associated with global cerebral hypomyelination. N Engl J Med 361: 489-495.
45. Woodruff RH, Tekki-Kessaris N, Stiles CD, Rowitch DH, Richardson WD. 2001. Oligodendrocyte development in the spinal cord and telencephalon: common themes and new perspectives. Int J Dev Neurosci 19: 379-385.
46. Zöller I, Büssow H, Gieselmann V, Eckhardt M. 2005. Oligodendrocyte-specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT-deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level. Glia 52: 190-198.